New Zealand markets closed

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.62-0.05 (-0.43%)
At close: 04:00PM EST
11.62 0.00 (0.00%)
After hours: 04:11PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
17,419
9,330
18,147
3,966
Operating expenses
Research development
60,506
67,003
65,775
33,885
Selling general and administrative
36,178
21,440
15,588
12,887
Total operating expenses
96,684
88,443
81,363
46,772
Operating income or loss
-79,265
-79,113
-63,216
-42,806
Total other income/expenses net
-155
432
963
1,144
Income before tax
-79,101
-78,280
-60,925
-41,662
Income from continuing operations
-79,101
-78,280
-60,925
-41,662
Net income
-79,101
-78,280
-60,925
-41,662
Net income available to common shareholders
-78,552
-78,280
-60,925
-41,662
Basic EPS
-
-3.52
-3.35
-2.60
Diluted EPS
-
-3.52
-3.35
-2.60
Basic average shares
-
22,386
18,161
16,002
Diluted average shares
-
22,386
18,161
16,002
EBITDA
-
-78,352
-62,466
-42,397